Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Feature Detection Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System: Complete Statistical AnalysisIndependent statistical analysis of Feature Detection Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn’s Colitis: Complete Statistical AnalysisIndependent statistical analysis of Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Fecal Microbiota Transplantation (FMT) for MDRO UTI: Complete Statistical AnalysisIndependent statistical analysis of Fecal Microbiota Transplantation (FMT) for MDRO UTI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03367910).
- FeDeriCaIndependent statistical analysis of A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive…
- Feeding My Baby – A National WIC Study: Complete Statistical AnalysisIndependent statistical analysis of Feeding My Baby - A National WIC Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02031978).
- FEELGOODIndependent statistical analysis of Expression of Longevity Genes in Response to Extended Fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01059760).
- FELINEIndependent statistical analysis of Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- FEM-PrEPIndependent statistical analysis of FEM-PrEP, a randomized phase 3 trial evaluating Truvada versus placebo for preventing HIV acquisition in women, including its time-to-event analysis, safety endpoints, secondary outcomes, and statistical interpretation.
- Femoral/Sciatic Block for Knee Surgery: Complete Statistical AnalysisIndependent statistical analysis of Femoral/Sciatic Block for Knee Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02882152).
- FEMZONEIndependent statistical analysis of Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer: primary endpoint results, effect estimate with confidence…
- Fenofibrate in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Fenofibrate in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03829514).
- Fenofibrate Treatment in SCI: Complete Statistical AnalysisIndependent statistical analysis of Fenofibrate Treatment in SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02455336).
- Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00288067).
- Fentanyl for Breakthrough Pain in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Fentanyl for Breakthrough Pain in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01812759).
- Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea: Complete Statistical AnalysisIndependent statistical analysis of Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01832402).
- Fentanyl Test in Children’s Adenotonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of Fentanyl Test in Children's Adenotonsillectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02484222).
- ferdonIndependent statistical analysis of Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FermCarbIndependent statistical analysis of Effect of Fermentable Carbohydrate on Glucose Homeostasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01841073).
- FERMINIndependent statistical analysis of FEnofibRate as a Metabolic INtervention for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04517396).
- Fetal and Infant Effects of Maternal Buprenorphine Treatment: Complete Statistical AnalysisIndependent statistical analysis of Fetal and Infant Effects of Maternal Buprenorphine Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01561079).
- Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion: Complete Statistical AnalysisIndependent statistical analysis of Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Fetal Tracheal Balloon Study in Diaphragmatic Hernia: Complete Statistical AnalysisIndependent statistical analysis of Fetal Tracheal Balloon Study in Diaphragmatic Hernia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00966823).
- Fetoscopic NEOX Cord 1K® Spina Bifida Repair: Complete Statistical AnalysisIndependent statistical analysis of Fetoscopic NEOX Cord 1K® Spina Bifida Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243889).
- Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense: Complete Statistical AnalysisIndependent statistical analysis of Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03974178).
- FFAADAIndependent statistical analysis of Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02406586).
- FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03212170).
- FGCRTIndependent statistical analysis of Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00999037).
- Fibrin Glue in Inguinal Lymphadenectomy: Complete Statistical AnalysisIndependent statistical analysis of Fibrin Glue in Inguinal Lymphadenectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04666051).
- Fibrin Melanoma Axillary Node Study in Patients With Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Fibrin Melanoma Axillary Node Study in Patients With Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00504582).
- Fibrin Sealant Vascular Surgery Study: Complete Statistical AnalysisIndependent statistical analysis of Fibrin Sealant Vascular Surgery Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00576420).
- Fibroblast Growth Factors 19 and 21 in Gestational Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Fibroblast Growth Factors 19 and 21 in Gestational Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01858597).
- FICUSIndependent statistical analysis of Family Support Intervention in Intensive Care Units: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05280691).
- FIDELIO-DKDIndependent statistical analysis of Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Field of Effects of Two Commercial Preparations of Botulinum Toxin Type A: Complete Statistical AnalysisIndependent statistical analysis of Field of Effects of Two Commercial Preparations of Botulinum Toxin Type A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FIGARO UC 303Independent statistical analysis of An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- FIGARO-DKDIndependent statistical analysis of FIGARO-DKD, a randomized phase 3 trial of finerenone versus placebo in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease.
- FIGARO-DKDIndependent statistical analysis of Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease: primary endpoint results, effect estimate with confidence interval,…
- FIGHT-210Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration: primary endpoint results, effect…
- FIGHT-302Independent statistical analysis of FIGHT-302, a randomized phase 3 trial of pemigatinib versus gemcitabine plus cisplatin in unresectable or metastatic cholangiocarcinoma, including progression-free survival, response, overall survival, statistical methodology, safety, and interpretation.
- Figure 8Independent statistical analysis of Femoral Vein Hemostasis After Ablation for Atrial Fibrillation With Manual Pressure Versus a Figure of 8 Suture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- FIL_GEMROIndependent statistical analysis of Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FILM-BIndependent statistical analysis of A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel…
- Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea – A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FINANCE-DMIndependent statistical analysis of Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04203173).
- Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02210832).
- Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program: Complete Statistical AnalysisIndependent statistical analysis of Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Financial Incentives to Translate ALLHAT Into Practice: A Randomized Trial: Complete Statistical AnalysisIndependent statistical analysis of Financial Incentives to Translate ALLHAT Into Practice: A Randomized Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00302718).
- Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- finCATIndependent statistical analysis of A Study of Cognitive Adaptation Training in Inpatient Forensic Environments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04294719).